These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 31733680)

  • 1. Procalcitonin: Where Are We Now?
    Hamade B; Huang DT
    Crit Care Clin; 2020 Jan; 36(1):23-40. PubMed ID: 31733680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ProCommunity: procalcitonin use in real-world US community hospital settings.
    DeSear KE; Thompson-Leduc P; Kirson N; Chritton JJ; Ie S; Van Schooneveld TC; Cheung HC; Ou S; Schuetz P
    Curr Med Res Opin; 2020 Sep; 36(9):1529-1532. PubMed ID: 32643964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interpretation of the concentrations of procalcitonin during infectious and inflammatory processes].
    Piatnitskiĭ IA; Sharandak AP; Zokina TG; Berner LP
    Ter Arkh; 2012; 84(12):120-4. PubMed ID: 23480003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Progress Note: Procalcitonin in the Management of Pediatric Lower Respiratory Tract Infection.
    Katz SE; Sartori LF; Williams DJ
    J Hosp Med; 2019 Nov; 14(11):688-690. PubMed ID: 31532736
    [No Abstract]   [Full Text] [Related]  

  • 7. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
    Schuetz P; Chiappa V; Briel M; Greenwald JL
    Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embracing Procalcitonin for Antimicrobial Stewardship.
    Chambliss AB
    J Appl Lab Med; 2019 Jan; 3(4):712-715. PubMed ID: 31639737
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers in sepsis: can they help improve patient outcome?
    Kyriazopoulou E; Poulakou G; Giamarellos-Bourboulis EJ
    Curr Opin Infect Dis; 2021 Apr; 34(2):126-134. PubMed ID: 33534419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin for guidance of antibiotic therapy.
    Schuetz P; Albrich W; Christ-Crain M; Chastre J; Mueller B
    Expert Rev Anti Infect Ther; 2010 May; 8(5):575-87. PubMed ID: 20455686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.
    Christ-Crain M; Müller B
    Eur Respir J; 2007 Sep; 30(3):556-73. PubMed ID: 17766633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin-guided antibiotic stewardship from newborns to centennials.
    Schuetz P; Mueller B
    Lancet; 2017 Aug; 390(10097):826-829. PubMed ID: 28711319
    [No Abstract]   [Full Text] [Related]  

  • 14. Procalcitonin Is Useful for Antibiotic Deescalation in Sepsis.
    Plata-Menchaca EP; Ferrer R
    Crit Care Med; 2021 Apr; 49(4):693-696. PubMed ID: 33315698
    [No Abstract]   [Full Text] [Related]  

  • 15. The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges.
    Fung AWS; Beriault D; Diamandis EP; Burnham CD; Dorman T; Downing M; Hayden J; Langford BJ
    Clin Chem; 2017 Sep; 63(9):1436-1441. PubMed ID: 28634222
    [No Abstract]   [Full Text] [Related]  

  • 16. Procalcitonin and Its Limitations: Why a Biomarker's Best Isn't Good Enough.
    Farooq A; Colón-Franco JM
    J Appl Lab Med; 2019 Jan; 3(4):716-719. PubMed ID: 31639738
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased antibiotic exposure using a procalcitonin protocol for respiratory infections and sepsis in US community hospitals (ProCommunity).
    DeSear KE; Thompson-Leduc P; Van Schooneveld TC; Kirson N; Chritton JJ; Ie S; Cheung HC; Ou S; Zimmer L; Schuetz P
    Curr Med Res Opin; 2021 May; 37(5):727-733. PubMed ID: 33617362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Procalcitonin as biomarker for infections].
    de Jonge JC; de Lange DW; Bij de Vaate EA; van Leeuwen H; Arends JE
    Ned Tijdschr Geneeskd; 2016; 160():D282. PubMed ID: 27734774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis.
    Hey J; Thompson-Leduc P; Kirson NY; Zimmer L; Wilkins D; Rice B; Iankova I; Krause A; Schonfeld SA; DeBrase CR; Bozzette S; Schuetz P
    Clin Chem Lab Med; 2018 Jul; 56(8):1200-1209. PubMed ID: 29715176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.